Arbutus Biopharma Corpora... (ABUS)
NASDAQ: ABUS
· Real-Time Price · USD
3.33
-0.04 (-1.19%)
At close: Aug 15, 2025, 3:59 PM
3.37
1.01%
After-hours: Aug 15, 2025, 05:47 PM EDT
Arbutus Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -54.25M | -76.57M | -69.92M | -76.7M | -77.09M | -74.39M | -72.85M | -75.47M | -72.93M | -70.03M | -69.46M | -68.84M | -70.44M | -75.63M | -76.25M | -71.97M | -71.56M | -66.27M |
Depreciation & Amortization | 1.01M | 1.35M | 1.38M | 1.41M | 1.44M | 1.43M | 1.4M | 1.35M | 1.33M | 1.37M | 1.43M | 1.55M | 1.65M | 1.7M | 1.75M | 1.81M | 1.86M | 1.92M |
Stock-Based Compensation | 8.22M | 10.54M | 8.99M | 9.08M | 9.4M | 9.18M | 9.3M | 9.24M | 8.48M | 7.58M | 7.18M | 6.95M | 6.85M | 6.53M | 6.42M | 6.42M | 6.5M | 6.35M |
Other Working Capital | 969.08K | 500.78K | 531.78K | 749.15K | -3.98M | -6.53M | -10.71M | -12.22M | -9.73M | -17.42M | 24.48M | 25.45M | 28.2M | 41.54M | 3.31M | 2.02M | 646K | 674K |
Other Non-Cash Items | -17.71M | 1.34M | 3.55M | 3.83M | 4.38M | 3.24M | -2.03M | -3.34M | -4.66M | -4.36M | -3.75M | -4.6M | -3.06M | -1.81M | -1.39M | -430K | 311K | 481K |
Deferred Income Tax | n/a | n/a | n/a | -1.5M | -2.17M | -2.71M | -2.71M | -1.21M | -534K | n/a | n/a | 241K | 497K | 791K | 994K | 781K | 3.1M | 2.89M |
Change in Working Capital | 2.54M | 5.3M | -2.83M | -864.36K | -1.75M | -8.51M | -17.99M | -16.21M | -14.22M | -17.83M | 29.24M | 26.74M | 29.19M | 39.39M | 930K | 441K | 724K | 749K |
Operating Cash Flow | -60.19M | -58.71M | -64.61M | -70.52M | -71.57M | -76.86M | -84.87M | -85.63M | -82.54M | -83.28M | -35.36M | -37.97M | -35.32M | -29.03M | -67.53M | -62.94M | -59.08M | -53.87M |
Capital Expenditures | -86K | -86.32K | -181.32K | -81.96K | -113.96K | -972.64K | -994.64K | -1.14M | -1.2M | -554K | -512K | -436K | -365K | -785K | -809K | -903K | -894K | -328K |
Cash Acquisitions | -37.19M | -37.19M | n/a | -265.1 | 37.21M | 34.91M | -2.55M | -2.57M | -2.59M | -268K | -1.76M | 70.65K | 70.92K | 51K | -18.28M | -19.65M | -19.65M | -19.65M |
Purchase of Investments | 47.37M | 258K | -35.77M | -15.63M | -87.71M | -84.73M | -79.54M | -69.65M | -95.22M | -88.65M | -130.43M | -145.33M | -112.69M | -142.17M | -82.22M | -110.83M | -113.81M | -63.24M |
Sales Maturities Of Investments | -22.35M | 19.5M | 56.69M | 44.69M | 141.25M | 130.9M | 130.71M | 112.03M | 113.5M | 91M | 56M | 50M | 47M | 52M | 70.35M | 57.2M | 60.8M | 71.78M |
Other Investing Acitivies | 40.64M | 49.69M | 49.43M | 49.44M | 10.19M | 2.76M | 2.57M | 2.57M | 2.57M | 268K | 1.76M | -50.65K | 15.94M | -22.18M | -3.84M | -2.47M | -20.96M | 40.59M |
Investing Cash Flow | 28.39M | 22.45M | 22.8M | 31.03M | 53.45M | 45.21M | 50.19M | 41.23M | 17.06M | 1.79M | -74.94M | -95.75M | -66.04M | -90.95M | -12.68M | -54.53M | -56.41M | 5.71M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12.14M | -12.14M | -12.14M | -15.35M | -15.34M | -15.34M | -15.34M |
Other Financial Acitivies | 6.43M | 6.33M | 6.21M | 4.74M | 3.25M | 2.9M | 795K | 841K | 715K | 828K | 11.49M | 23.51M | 25.57M | 25.47M | 17.92M | 18.05M | 16.17M | 16.07M |
Financial Cash Flow | 6.43M | 30M | 51.65M | 53.65M | 53.55M | 34.27M | 30.26M | 37.92M | 45.38M | 40.75M | 31.81M | 79.85M | 117.67M | 121.85M | 137.24M | 98.33M | 100.47M | 101.14M |
Net Cash Flow | -25.38M | -6.03M | 10.04M | 14.31M | 35.59M | 2.53M | -4.49M | -6.47M | -20.12M | -40.76M | -78.51M | -53.88M | 16.37M | 1.91M | 57.03M | -19.04M | -14.95M | 53.01M |
Free Cash Flow | -60.28M | -58.79M | -64.79M | -70.6M | -71.68M | -77.84M | -85.86M | -86.78M | -83.74M | -83.83M | -35.87M | -38.41M | -35.68M | -29.82M | -68.34M | -63.84M | -59.97M | -54.2M |